test

Jennifer Ciresi

@Redmile Group, Llc

Latest period2024 - Q3ReportedManaged Assets$1.697BTotal holdings63
Assets growth rate2.63%Assets growth rate (2-Q avg)-18.33%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Redmile Group, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 63 positions.

Assets under management

The assets under management (AUM) of Redmile Group, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.697B in assets, with a quarterly growth rate of 2.63% and a 2-quarter average growth rate of -18.33%. The portfolio is managed by Jennifer Ciresi, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
SRRKScholar Rock Hldg Corp
Recent Activity
Decreased -3.92%
2.48%
$41.963M
5.239M shares@ $8.01 avg price
NGNENeurogene Inc
Recent Activity
Decreased -4.86%
2.39%
$40.464M
964,347 shares@ $41.96 avg price
AKROAkero Therapeutics Inc
Recent Activity
Decreased -14.05%
2.35%
$39.807M
1.387M shares@ $28.7 avg price
BEAMBeam Therapeutics Inc
Recent Activity
Decreased -5.4%
2.33%
$39.47M
1.611M shares@ $24.51 avg price
PLRXPliant Therapeutics Inc
Recent Activity
Decreased -0.37%
2.12%
$35.844M
3.197M shares@ $11.21 avg price
SLNSilence Therapeutics Plc
Recent Activity
Decreased -5.7%
2.04%
$34.53M
1.899M shares@ $18.18 avg price
BSXBoston Scientific Corp
Recent Activity
Decreased -15.21%
1.64%
$27.727M
330,873 shares@ $83.8 avg price
CLDXCelldex Therapeutics Inc New
Recent Activity
Decreased -8.56%
1.32%
$22.337M
657,175 shares@ $33.99 avg price
IDYAIdeaya Biosciences Inc
Recent Activity
Decreased -10.31%
1.28%
$21.579M
681,150 shares@ $31.68 avg price
IMVTImmunovant Inc
Recent Activity
Decreased -10.82%
1.08%
$18.31M
642,229 shares@ $28.52 avg price